Seymour H. Fein

Seymour H.
Fein is the founder of Serenity Pharmaceuticals Corp., founded in 2007, serving as Chief Medical Officer & Principal.
Current jobs include Chief Medical & Regulatory Officer at Oncotelic Therapeutics, Inc. since 2023, and Chief Medical Officer at Ventria Bioscience, Inc. since 2015.
Former jobs include Medical Director at Bayer Pharmaceuticals Corp., Independent Director at Prospect Park Capital Corp.
from 2016 to 2020, Medical Director at Bayer HealthCare Pharmaceuticals, Inc., Director-Clinical Research & Development at Ohmeda PPD, Inc., Medical Director at Rorer Group, Inc., Medical Director at Ohmeda, Inc., Chief Medical Officer at Oncotelic Therapeutics, Inc., Chief Medical Officer at Delcath Systems, Inc. from 2006 to 2008, Senior Research Physician at Hoffmann-La Roche, Inc., Principal at US Food & Drug Administration, and Chief Medical Officer at Adhera Therapeutics, Inc. Education includes undergraduate studies at the University of Pennsylvania and a doctorate from New York Medical College.